SEC Form 4 · accession 0001209191-15-036340
KalVista Pharmaceuticals, Inc. · KALV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Reza Zadno
Director
Period of report
Apr 24, 2015
Accepted (ET)
Apr 27, 2015 · 2:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.45 | Apr 24, 2015 | A | 6,250 | A | Apr 24, 2015 | Apr 24, 2025 | Common Stock | 6,250 | 6,250 | D |